In a scopolamine-induced memory impairment rat model, Arafa et al. observed the beneficial effects of another SGLT-2 inhibitor, canagliflozin, suggesting a potential acetylcholinesterase inhibitory activity as an additional property of SGLT2 inhibitors [257]. Here, SLC5A2 is linked to memory impairment.